Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 679.13B, Johnson & Johnson(JNJ) trades at $281.60. The stock has a price-to-earnings ratio of 41.90 and currently yields dividends of 1.91%.
On 2026-11-09, Johnson & Johnson(JNJ) stock traded between a low of $276.20 and a high of $282.73. Shares are currently priced at $281.60, which is +2.0% above the low and -0.4% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.9M, against a daily average of 7.59M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $282.73 and a 52-week low of $185.12.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $282.73 and a 52-week low of $185.12.
JNJ News
Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson (Johnson & Johnson) (NYSE:JNJ) concerning possible violations of...
...
Johnson & Johnson (NYSE:JNJ) highlighted encouraging clinical advancements on Saturday across two major immunology programs, presenting positive Phase 3 data fo...
Analyst ratings
67%
of 27 ratingsMore JNJ News
Investing After the Democratic Midterm Sweep: 4 Dividend Stocks Built for Gridlock When Congress locks up, some dividends barely notice. Four blue chips span po...
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The result...
J&J reports patient findings from Sjögren’s drug study Nov 08, 2026, 2:36 PM ET Johnson & Johnson (JNJ) Stock By : Rob Williams, SA News Editor Johnson & Johnso...
Johnson & Johnson (NYSE:JNJ) reported highly promising Phase 3 trial results for its oral psoriatic arthritis drug ICOTYDE on 7 November 2026. The Phase 3 data...
On Thursday, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Johnson & Johnson’s (NYSE:JNJ) Rybrevant Faspro as a single agent for a...
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Bayer Aktiengesellschaft (BAYRY Quick QuoteBAYRY - Fre...
Traders now price an 80% chance the Fed hikes again in December, and Treasuries yield more than every dividend stock on this list. Four income names have a reco...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.